| drug class | Keratolytics |
| description | A class of topical medications used to remove or soften thickened skin layers. |
| general information | | mechanism of action | Keratolytics work by dissolving or disrupting the bonds within the keratin protein of the skin, thereby softening and loosening the affected layers. | | route of administration | Primarily topical application. | | absorption | Variable, depending on the specific keratolytic and route of administration. Often limited to topical application with minimal systemic absorption. |
|
| pharmacokinetics | | absorption | Variable, depending on the specific agent and route of administration. Often limited to topical application, with minimal systemic absorption. | | distribution | Primarily localized to the area of application; distribution dependent on the specific agent. | | metabolism | Metabolism varies significantly among different keratolytic agents. Some are metabolized in the liver, others are not significantly metabolized. | | excretion | Excretion primarily through the skin, with some potential for excretion via the kidneys or other routes. |
|
| dosage and administration | | general note | Dosage varies significantly depending on the specific keratolytic agent, the condition being treated, and the patient's specific needs. Always consult a healthcare professional for specific instructions. |
|
| indications | | 1 | Treatment of acne vulgaris | | 2 | Treatment of psoriasis | | 3 | Treatment of calluses and corns | | 4 | Treatment of warts | | 5 | Treatment of other skin conditions involving hyperkeratosis (thickened skin) |
|
| safety considerations | | pregnancy | Limited data for many keratolytics. Use during pregnancy requires careful consideration by a healthcare professional. Potential risks to the developing fetus must be weighed against the benefits of treatment. Avoid use during the first trimester whenever possible. | | breastfeeding | Limited data for many keratolytics. Some may be excreted in breast milk. Consult a healthcare professional before use during breastfeeding. |
|
| potential side effects | | 1 | Skin irritation | | 2 | Burning | | 3 | Redness | | 4 | Dryness | | 5 | Pruritus (itching) | | 6 | Pain | | 7 | Contact dermatitis (in some cases) | | 8 | Temporary skin discoloration (in some cases) |
|
| alternative treatments | | 1 | | | 2 | | name | Lactic acid | | additional info | Commonly used for skin exfoliation, often well-tolerated |
| | 3 | | name | Urea | | additional info | Common ingredient in skin moisturizers and keratolytic products |
| | 4 | | name | Tretinoin | | additional info | Often used for acne and aging skin but not a keratolytic itself; may be used in conjunction with other keratolytics |
| | 5 | | name | Azelaic acid | | additional info | An effective option for acne and rosacea, and may have some keratolytic effects. |
|
|
| contraindications | | 1 | Known hypersensitivity to any component of the keratolytic agent | | 2 | Open or damaged skin (in the area of application) | | 3 | Use in or around the eyes |
|
| drug interactions | May interact with other topical medications or treatments. Always inform your physician of all medications, supplements, and other treatments you are taking. |
| warnings and precautions | | 1 | Follow directions carefully. Do not exceed recommended dosage. | | 2 | Apply only to the affected area(s). | | 3 | Stop use and consult a healthcare professional if irritation or other adverse reactions occur. | | 4 | Protect the skin from excessive sun exposure when using certain keratolytics. |
|
| patient specific considerations | Patient age and weight are not typically primary factors in determining keratolytic dosage. Always consult with a healthcare professional to determine the proper dosage and treatment plan. |
| important notes | This information is a general overview of keratolytics. Consult a healthcare professional for specific details related to any individual keratolytic agent or treatment plan. |
